Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Where Is OxyContin Abuse Deterrent Data? Purdue Has Sent Two Studies, But Wait Continues

Jan 27 2019

• By Brenda Sandburg

Related Content

US FDA’s Most Unusual Advisory Committee

Dec 26 2018

Opioid Sponsors Enter 2019 At A Crossroads

Dec 31 2018

Mallinckrodt's Abuse Deterrent Oxycodone IR Narrowly Wins US FDA Panel Backing

Nov 15 2018

Purdue's reformulated OxyContin gets US panel backing on second try

Sep 25 2009

Purdue's Pain And No Gain: More Analysis Of OxyContin Postmarket Studies Needed

Jun 30 2015

Related Companies

Mallinckrodt plc

Purdue Pharma L.P.

Pfizer Inc.

Allergan plc

Endo, Inc.

Teva Pharmaceutical Industries Ltd.

Additional Topics

United States Post Market Regulation & Studies Drug Safety Regulation Drug Review Neurology BioPharmaceutical

More from Post-Marketing Regulation & Studies

More from Product Reviews

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window